Genetically engineered pigs and targetspecific immunomodulation provide significant
- Slides: 5
Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation Muhammad M. Mohiuddin, MD, Avneesh K. Singh, Ph. D, Philip C. Corcoran, MD, Robert F. Hoyt, DVM, Marvin L. Thomas, DVM, David Ayares, Ph. D, Keith A. Horvath, MD The Journal of Thoracic and Cardiovascular Surgery Volume 148 Issue 3 Pages 1106 -1114 (September 2014) DOI: 10. 1016/j. jtcvs. 2014. 06. 002 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 The Journal of Thoracic and Cardiovascular Surgery 2014 1481106 -1114 DOI: (10. 1016/j. jtcvs. 2014. 06. 002) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 The Journal of Thoracic and Cardiovascular Surgery 2014 1481106 -1114 DOI: (10. 1016/j. jtcvs. 2014. 06. 002) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 3 The Journal of Thoracic and Cardiovascular Surgery 2014 1481106 -1114 DOI: (10. 1016/j. jtcvs. 2014. 06. 002) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 4 The Journal of Thoracic and Cardiovascular Surgery 2014 1481106 -1114 DOI: (10. 1016/j. jtcvs. 2014. 06. 002) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
